In this study we report the behavior of two PPAR enantiomeric ligands (R-1 and S-1). Cell-based reporter assays indicate that both enantiomers are dual PPAR{alpha}/{gamma} ligands, being R-1 a full agonist of PPAR{alpha} and {gamma} and S-1 a partial agonist of PPAR{gamma}. 3D-structure analysis of the PPAR{gamma} ligand binding domain in the complex with the two ligands shows that the suboptimal conformation of helix 12 in the PPAR{gamma}/S-1 complex is the consequence of a steric hindrance between the ethyl group of the ligand and the Q286 in helix 3. Site-directed mutagenesis confirms that Q286 is a key residue in determining the activity of different ligands. By using FRET assays, we found that the coactivators SRC-1, PGC-1{alpha}, RIP140, TIF-2 are recruited by R-1, S-1 and rosiglitazone with similar EC50, whereas CBP affinity is higher in the presence of rosiglitazone. Conversely, only S-1 allows the association of the corepressor N-CoR to PPAR{gamma} as opposed to rosiglitazone and R-1, providing a functional explanation to the partial agonist behavior of S-1. ChIP assays confirmed that S-1 enhances the association of N-CoR to PPAR{gamma} target promoters in the native chromatin context, whereas rosiglitazone and R-1 recruit less N-CoR. Altogether, our results provide a rationale for the distinct behavior of different PPAR ligands.
Characterization of two synthetic ligands of peroxisomeproliferator-activated receptor γ (PPARγ) by cofactorrecruitment, site-directed mutagenesis and structure analysis / M., Crestani; N., Mitro; F., Gilardi; E., Scotti; G., Pochetti; Lavecchia, Antonio; Novellino, Ettore; G., Fracchiolla; A., Laghezza; P., Tortorella; M., Aschi; F., Mazza; R., Montanari; F., Loiodice. - In: THE FASEB JOURNAL. - ISSN 0892-6638. - (2010), pp. lb200-lb200.
Characterization of two synthetic ligands of peroxisomeproliferator-activated receptor γ (PPARγ) by cofactorrecruitment, site-directed mutagenesis and structure analysis
LAVECCHIA, ANTONIO;NOVELLINO, ETTORE;
2010
Abstract
In this study we report the behavior of two PPAR enantiomeric ligands (R-1 and S-1). Cell-based reporter assays indicate that both enantiomers are dual PPAR{alpha}/{gamma} ligands, being R-1 a full agonist of PPAR{alpha} and {gamma} and S-1 a partial agonist of PPAR{gamma}. 3D-structure analysis of the PPAR{gamma} ligand binding domain in the complex with the two ligands shows that the suboptimal conformation of helix 12 in the PPAR{gamma}/S-1 complex is the consequence of a steric hindrance between the ethyl group of the ligand and the Q286 in helix 3. Site-directed mutagenesis confirms that Q286 is a key residue in determining the activity of different ligands. By using FRET assays, we found that the coactivators SRC-1, PGC-1{alpha}, RIP140, TIF-2 are recruited by R-1, S-1 and rosiglitazone with similar EC50, whereas CBP affinity is higher in the presence of rosiglitazone. Conversely, only S-1 allows the association of the corepressor N-CoR to PPAR{gamma} as opposed to rosiglitazone and R-1, providing a functional explanation to the partial agonist behavior of S-1. ChIP assays confirmed that S-1 enhances the association of N-CoR to PPAR{gamma} target promoters in the native chromatin context, whereas rosiglitazone and R-1 recruit less N-CoR. Altogether, our results provide a rationale for the distinct behavior of different PPAR ligands.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.